REGULATORY INTELLIGENCE·Recall
Eugia US LLC Initiates Nationwide Class III Recall of Lidocaine HCl Injection Due to Labeling Deficiencies
Eugia US LLC has initiated a nationwide Class III recall for 168,300 vials of Lidocaine HCl Injection, USP 2%, due to label wrap obstructing barcodes. This voluntary, firm-initiated action impacts procurement and supply chain continuity for a critical injectable. Decision-makers must assess their exposure to Eugia's supply and explore diversified sourcing strategies to mitigate operational risks and ensure patient access.
90-Day Activity